NASDAQ:IRTC

iRhythm Technologies Stock Forecast, Price & News

$52.07
+1.57 (+3.11 %)
(As of 07/28/2021 03:45 PM ET)
Add
Compare
Today's Range
$51.29
$52.72
50-Day Range
$50.09
$76.33
52-Week Range
$48.71
$286.19
Volume7,201 shs
Average Volume670,326 shs
Market Capitalization$1.53 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.47
30 days | 90 days | 365 days | Advanced Chart
Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.


iRhythm Technologies logo

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.47 out of 5 stars

Medical Sector

981st out of 2,210 stocks

Surgical & Medical Instruments Industry

96th out of 185 stocks

Analyst Opinion: 3.1Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

Is iRhythm Technologies a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" iRhythm Technologies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRTC, but not buy additional shares or sell existing shares.
View analyst ratings for iRhythm Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than iRhythm Technologies?

Wall Street analysts have given iRhythm Technologies a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iRhythm Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting iRhythm Technologies?

iRhythm Technologies saw a increase in short interest in June. As of June 30th, there was short interest totaling 2,210,000 shares, an increase of 22.1% from the June 15th total of 1,810,000 shares. Based on an average daily trading volume, of 781,700 shares, the days-to-cover ratio is presently 2.8 days. Approximately 7.7% of the company's shares are short sold.
View iRhythm Technologies' Short Interest
.

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for iRhythm Technologies
.

How can I listen to iRhythm Technologies' earnings call?

iRhythm Technologies will be holding an earnings conference call on Thursday, August 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its earnings results on Thursday, May, 6th. The company reported ($0.95) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.87) by $0.08. The company had revenue of $74.31 million for the quarter, compared to analyst estimates of $70.35 million. iRhythm Technologies had a negative net margin of 22.67% and a negative trailing twelve-month return on equity of 22.67%. The company's revenue was up 17.0% on a year-over-year basis. During the same period last year, the firm posted ($0.34) EPS.
View iRhythm Technologies' earnings history
.

How has iRhythm Technologies' stock price been impacted by COVID-19?

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IRTC shares have decreased by 39.1% and is now trading at $52.07.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for IRTC?

11 brokers have issued 12 month price objectives for iRhythm Technologies' stock. Their forecasts range from $80.00 to $273.00. On average, they expect iRhythm Technologies' stock price to reach $168.73 in the next twelve months. This suggests a possible upside of 224.0% from the stock's current price.
View analysts' price targets for iRhythm Technologies
or view top-rated stocks among Wall Street analysts.

Who are iRhythm Technologies' key executives?

iRhythm Technologies' management team includes the following people:
  • Mr. Douglas J. Devine, CFO, Sec. & Interim CEO (Age 51, Pay $573.16k)
  • Mr. Daniel G. Wilson, Exec. VP of Strategy, Corp. Devel. & Investor Relations
  • Mr. David A. Vort, Exec. VP of Sales (Age 55, Pay $552.1k)
  • Mr. Mark J. Day Ph.D., Exec. VP of R&D (Age 50, Pay $538.43k)
  • Mr. Kevin M. King, Consultant & Director (Age 65, Pay $1.39M)
  • Mr. Matthew C. Garrett, Advisor (Age 53, Pay $405.04k)
  • Ms. Marga Ortigas-Wedekind, Exec. VP of Marketing (Age 59)
  • Ms. Kaja J. Odegard, VP of HR (Age 39)
  • Ms. Judith C. Lenane, Chief Clinical Officer & Exec. VP of Operations (Age 62)
  • Mr. Allan B. Wilsker, Exec. VP of Information Technology & Customer Service (Age 62)

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies CEO Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of iRhythm Technologies' key competitors?

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), The Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.01%). Company insiders that own iRhythm Technologies stock include David A Vort, Kevin M King, Mark J Day, Matthew C Garrett, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies
.

Which major investors are selling iRhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold iRhythm Technologies company stock in the last year include David A Vort, Kevin M King, and Mark J Day.
View insider buying and selling activity for iRhythm Technologies
or view top insider-selling stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $52.07.

How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of $1.53 billion and generates $265.17 million in revenue each year. The company earns $-43,830,000.00 in net income (profit) each year or ($1.58) on an earnings per share basis.

How many employees does iRhythm Technologies have?

iRhythm Technologies employs 1,157 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is www.irhythmtech.com.

Where are iRhythm Technologies' headquarters?

iRhythm Technologies is headquartered at 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]


This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.